Regulation of interactions of endotoxin with host cells

Abstract

Potent Toll-like receptor 4 (TLR4)-dependent cell activation by endotoxin requires lipopolysaccharide-binding protein (LBP) and CD14-dependent delivery of endotoxin to cells containing MD-2 and TLR4. We have used metabolically labeled [¹⁴C] meningococcal lipooligosaccharide (LOS), purified recombinant endotoxin-binding proteins, and cultured endothelial cells to better define protein: endotoxin intermediates key in cell activation in the absence of functional membrane (m) CD14. Protein:endotoxin complexes or aggregates (agg) were purified by gel sieving and characterized by immunocapture and bio-assays. Cell activation closely correlated with LBP, albumin and soluble (s) CD14-dependent conversion of endotoxin agg (M_r ≥ 20 × 10⁶) to monomeric (M ~55 × 10³) endotoxin:sCD14 complexes. Ordered interaction of LBP (+ albumin) and sCD14 with ^rLOSagg was required for the efficient formation of a bioactive endotoxin:sCD14 complex and potent cell activation. Increasing the ratio of LBP/sCD14 or addition of bactericidal/permeability-increasing protein (BPI) reduced accumulation of endotoxin:sCD14 complexes and instead yielded aggregates of endotoxin (M_r ~1—20 × 10⁶) containing LBP or BPI that were taken up by cells in a CD14- and TLR4-independent manner without inducing pro-inflammatory responses. These findings strongly suggest that host machinery linked to TLR4-dependent cellular activation or TLR4-independent cellular clearance of endotoxin selectively recognizes different protein:endotoxin complexes. At the outset of infection, the low concentrations of LBP present and absence of extracellular BPI favor formation of pro-inflammatory endotoxin:CD14 complexes. The mobilization of LBP and BPI that is triggered by inflammation directs endotoxin for clearance and hence resolution of endotoxin-triggered inflammation.

References

Alexander C. , Rietschel ETh. Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 2001; 7: 167—202.

Heumann D. , Roger T. Initial responses to endotoxins and Gram-negative bacteria. Clin Chim Acta 2002; 323: 59—72.

Ulevitch RJ , Tobias PS Recognition of Gram-negative bacteria and endotoxin by the innate immune system . Curr Opin Immunol 1999; 11: 19—22.

Beutler B. Endotoxin , Toll-like receptor 4, and the afferent limb of innate immunity. Curr Opin Microbiol 2000; 3: 23—28.

Nagai Y. , Akashi A. , Nagafuku M. et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution . Nat Immunol 2002; 3: 667—672.

Bainbridge BW , Darveau RP Porphyromonas gingivalis lipopolysaccharide: an unusual pattern recognition receptor ligand for the innate host defense system. Acta Odontol Scand 2001; 59: 131—138.

Nagai Y. , Shimazu R. , Ogata H. et al. Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Blood 2002; 99: 1699—1705.

Perera PY , Mayadas TN , Takeuchi O. et al. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression . J Immunol 2001; 166: 574—581.

Tobias PS , Soldau K. , Ulevitch RJ Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J Biol Chem 1989; 264: 10867—10876.

10.

Hailman E. , Lichenstein HS , Wurfel MM et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14, J Exp Med 1994; 179: 269—277.

11.

Viriyakosol S. , Tobias PS , Kitchens RL , Kirkland TN MD-2 binds to bacterial lipopolysaccharide . J Biol Chem 2001; 276: 38044—38051.

12.

Giardina PC , Gioannini T. , Buscher B. et al. Construction of acetate auxotrophs of Neisseria meningitidis to study host-meningococcal endotoxin interactions . J Biol Chem 2001; 276: 5883—5891.

13.

Weinrauch Y. , Foreman A. , Shu C. et al. Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate. J Clin Invest 1995; 95: 1916—1924.

14.

Gioannini TL , Zhang DS , Teghanemt A. , Weiss JP An essential role for albumin in the interaction of endotoxin with lipopolysaccharide-binding protein and sCD14 and resultant cell activation. J Biol Chem 2002; 277: 47818—47825.

15.

Munford RS , DeVeaux LC , Cronan Jr JE, Rick PD. Biosynthetic radiolabeling of bacterial lipopolysaccharide to high specific activity. J Immunol Methods 1992; 148: 115—120.

16.

De Voe IW , Gilchrist JE Release of endotoxin in the form of cell wall blebs during in vitro growth of Neisseria meningitidis. J Exp Med 1973; 138: 1156—1167.

17.

Eastvold J. , Zhang DS , Gioannini TL , Weiss J. Purification and functional characterization of metabolically labeled membrane blebs from an acetate auxotroph of Neisseria meningitidis serogroup B [Abstract]. J Endotoxin Res 2002; 8: 209.

18.

Juan TS , Kelley MJ , Johnson DA et al. Soluble CD14 truncated at amino acid 152 binds lipopolysaccharide (LPS) and enables cellular response to LPS. J Biol Chem 1995; 270: 1382—1387.

19.

Jersmann HP , Hii CS , Hodge GL , Ferrante A. Synthesis and surface expression of CD14 by human endothelial cells. Infect Immun 2001 ; 69: 479—485.

20.

Tobias PS , Soldau K. , Iovine NM , Elsbach P. , Weiss J. Lipopolysaccharide (LPS)-binding proteins BPI and LBP form different types of complexes with LPS. J Biol Chem 1997; 272: 18682—18685.

21.

Iovine N. , Eastvold J. , Elsbach P. , Weiss JP , Gioannini TL The carboxyl-terminal domain of closely related endotoxin-binding proteins determines the target of protein-lipopolysaccharide complexes. J Biol Chem 2002; 277: 7970—7978.

22.

Thomas CJ , Kapoor M. , Sharma S. et al. Evidence of a trimolecular complex involving LPS, LPS binding protein and soluble CD14 as an effector of LPS response. FEBS Lett 2002; 531: 184—188.

23.

Wollenweber HW , Morrison DC Synthesis and biochemical characterization of a photoactivatable, iodinatable, cleavable bacterial lipopolysaccharide derivative. J Biol Chem 1985; 260: 15068—15074.

24.

Dziarski R. Cell-bound albumin is the 70-kDa peptidoglycan-, lipopolysaccharide-, and lipoteichoic acid-binding protein on lymphocytes and macrophages. J Biol Chem 1994; 269: 20431—20436.

25.

Elsbach P. , Weiss J. Role of the bactericidal/permeability-increasing protein in host defense. Curr Opin Immunol 1998; 10: 45—49.

26.

Han J. , Mathison JC , Ulevitch RJ , Tobias PS Lipopolysaccharide (LPS) binding protein, truncated at Ile-197, binds LPS but does not transfer LPS to CD14. J Biol Chem 1994; 269: 8172—8175.

27.

Theofan G. , Horwitz AH , Williams RE et al. An amino-terminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD 14-stimulatory activity. J Immunol 1994; 152: 3623—3629.

28.

Yu B. , Wright SD Catalytic properties of lipopolysaccharide (LPS) binding protein. Transfer of LPS to soluble CD14. J Biol Chem 1996; 271: 4100—4105.

29.

Lamping N. , Dettmer R. , Schroder NW et al. LPS-binding protein protects mice from septic shock caused by LPS or Gram-negative bacteria. J Clin Invest 1998; 101: 2065—2071.

30.

Zweigner J. , Gramm HJ , Singer OC , Wegscheider K. , Schumann RR High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood 2001; 98: 3800—3808.

31.

Tobias PS , Tapping RI , Gegner JA Endotoxin interactions with lipopolysaccharide-responsive cells. Clin Infect Dis 1999; 28: 476—481.

32.

Hamann L. , Stamme C. , Ulmer AJ , Schumann RR Inhibition of LPS-induced activation of alveolar macrophages by high concentrations of LPS-binding protein. Biochem Biophys Res Commun 2002; 295: 553—560.

33.

Gegner JA , Ulevitch RJ , Tobias PS Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J Biol Chem 1995; 270: 5320—5325.

34.

Tapping RI , Tobias PS Cellular binding of soluble CD14 requires lipopolysaccharide (LPS) and LPS-binding protein. J Biol Chem 1997; 272: 23157—23164.

35.

Wurfel MM , Kunitake ST , Lichenstein H. , Kane JP , Wright SD Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med 1994; 180: 1025—1035.

36.

Vreugdenhil Ace , Rousseau CH , Hartung T. , Greve Jwm , van't Veer C. , Buurman WA Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons. J Immunol 2003; 170: 1399—1405.

37.

Weinrauch Y. , Katz SS , Munford RS , Elsbach P. , Weiss J. Deacylation of purified lipopolysaccharides by cellular and extracellular components of a sterile rabbit peritoneal inflammatory exudate. Infect Immun 1999; 67: 3376—3382.

38.

Katz SS , Weinrauch Y. , Munford RS , Elsbach P. , Weiss J. Deacylation of lipopolysaccharide in whole Escherichia coli during destruction by cellular and extracellular components of a rabbit peritoneal inflammatory exudate. J Biol Chem 1999; 274: 36579-36584.